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Background: There is a need for psychosocial interventions for men with prostate cancer to promote adaptive
coping with the challenges and distress associated with diagnosis, treatment and recovery. In addition,
interventions are needed that help to overcome barriers to psychosocial treatment such as limited face-to-face
psychosocial support services, a shortage of adequately trained professionals, geographical distance, perceived and
personal stigma and a preference for consumer-centric and self-directed learning. My Road Ahead is an online
cognitive behaviour therapy (CBT) intervention for prostate cancer. This protocol describes a randomised controlled
trial (RCT) that will evaluate the efficacy of this online intervention alone, the intervention in combination with a
moderated online forum, and the moderated online forum alone.
Methods/design: This study utilises a RCT design with three groups receiving: 1) the 6-module My Road Ahead
intervention alone; 2) the My Road Ahead intervention plus a moderated online forum; and 3) the moderated
online forum alone. It is expected that 150 men with localised prostate cancer will be recruited into the RCT. Online
measures will assess men’s psychological distress as well as sexual and relationship adjustment at baseline, post-
intervention, 3 month follow-up and 6 month follow-up. The study is being conducted in Australia and participants
will be recruited from April 2012 to Feb 2014. The primary aim of this study is to evaluate the efficacy of My Road
Ahead in reducing psychological distress.
Discussion: To our knowledge, My Road Ahead is the first self-directed online psychological intervention developed
for men who have been treated for localised prostate cancer. The RCT will assess the efficacy of this intervention in
improving psychological well-being, sexual satisfaction, relationship satisfaction and overall quality of life. If successful,
this intervention could provide much needed support to men receiving treatment for localised prostate cancer in a
highly accessible manner.
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Prostate cancer is the most commonly diagnosed non-
melanoma skin cancer in males worldwide. In Australia,
19,403 men were diagnosed with prostate cancer in 2007
[1] and Australian men have a 1 in 7 chance of diagnosis
of prostate cancer by age 75 and a 1 in 4 chance by age
85 [1]. Registry data demonstrates that 93% of men have
localised disease at diagnosis in contemporary practice
in Australia [2]. Survival rates have increased over time
and 5-year prostate cancer related survival is now 92%
in Australia [3]. While treatment advances have contrib-
uted to this significant improvement in survival, all
treatment options will result in significant decrements in
quality of life (QoL) including erectile dysfunction (ED),
urinary incontinence and bowel urgency [4]. These re-
sidual symptoms can be very difficult for the patient [5]
given their significant impact on the patient’s general
quality of life (QoL) [6]. Survivorship issues in the pros-
tate cancer patient population therefore pose unique
challenges in terms of enhancing outcomes and reducing
the negative impact on QoL.
To date, QoL research has generally focussed on the
physical impact of treatments on prostate cancer pa-
tients. However, research investigating the impact of
prostate cancer treatment on psychological well-being is
increasing [7-12]. The results of these studies have re-
vealed that among those who have had prostate cancer
treatment, the prevalence of mood, anxiety and adjust-
ment disorders ranges from 9-24% [8,10,13,14]. The re-
sults from other studies suggest that physical side effects
of prostate cancer treatment (such as incontinence and
sexual dysfunction) are especially associated with anxiety
and depressive symptoms [9].
Patients also report high levels of unmet need in relation
to their prostate cancer experience with one Australian
study finding that 74% of men report some form of unmet
need in relation to their prostate cancer diagnosis [15].
The most commonly reported area of unmet need was in
the psychological support domain where 54% of men
expressed that they felt some level of unmet psychological
support need [15]. Sexuality was reported by 47% of men
as an area where they had some level of need for assist-
ance or support [15].
Psychosocial interventions for men treated for localised
prostate cancer
The efficacy of psychosocial support has been repeatedly
reported in the general cancer setting. Unfortunately, ac-
cess to evidence-based and timely psychosocial support
is often limited, particularly in rural and remote regions
of Australia but also in public hospitals across the coun-
try and, indeed, worldwide. It has been reported that
only 14 to 21% of Australian women with cancer attend
face-to-face support [16,17]. Men are lower utilisers ofhealth services in general [18] and international reports
indicate that mental health service utilisation by men is
lower than women [19].
A recent systematic review of psychosocial interven-
tions for men with prostate cancer and their partners
highlighted the poor quality of current research in this
field [20]. The authors concluded that group cognitive-
behavioural and psycho-educational interventions with a
specific focus on cancer specific distress show the most
robust research evidence for efficacy, however, further
research is required [20]. Another review explored psy-
chosocial interventions addressing sexual or relationship
functioning in men treated for prostate cancer [21]. This
review concluded that there is some evidence to support
the efficacy of psychosocial interventions in improving
sexual functioning especially when delivered face-to-face
or through utilisation of complex interventions that spe-
cifically target sexuality and the relationship. However, this
review also concluded that further research is required
[21]. Related to sexuality and intimacy, masculinity is
emerging as an important area [22] and yet it is not rou-
tinely addressed and integrated into interventions.
Online interventions
Mental and behavioural health promotion, prevention,
treatment and management-oriented interventions that
are delivered via the internet or other electronic technolo-
gies, with or without human support [23], often referred
to as “e-Interventions”, can overcome many barriers of ac-
cess that are commonly encountered in our healthcare
system. Whilst the use of e-Interventions has grown in
both the mental health and general health setting [24-26]
it has received limited attention in the cancer setting.
In the cancer setting, most online research has focused
on developing and evaluating online peer support inter-
ventions with mixed outcomes in female cancer samples
[27-29]. van den Brink [30] developed an online infor-
mation and support intervention for head and neck
cancer patients in the Netherlands with the aim of over-
coming the communication and information bottlenecks
in supportive head and neck cancer care. The authors
reported that patient use and satisfaction with the inter-
vention was very high despite patients having recently
undergone intensive surgical treatment. Patient age was
not a barrier (mean age 59 years and range 38-78) and,
despite 56% of participants having limited computer ex-
perience prior to the use of the intervention, consistently
positive feedback was received. This online support
intervention showed improved QoL outcomes in partici-
pants as compared to those in a control group who did
not access the intervention [30]. However, the interven-
tion focused on psycho-education and support rather
than skills in coping with the experience of cancer diag-
nosis, treatment and recovery.
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of an online sexual counselling intervention in compari-
son to traditional face-to-face sexual counselling for
couples following treatment for localised prostate can-
cer. Sexual counselling involved three face-to-face ses-
sions with a therapist while the online intervention
delivered the therapy via email contact with a therapist.
This study found that the delivery of the intervention via
the internet was as effective as the traditional face-to-
face intervention in producing enduring improvements
in sexual outcomes [31]. While this study highlighted
the potential utility of online interventions in this popu-
lation, to date, no online self-directed intervention with
minimal support and a focus on a range of identified
problem areas has been developed and evaluated for
localised prostate cancer.
A recent review by Leykin et al. [32] explored the role
of online interventions in supporting people with cancer.
This review highlighted that e-Interventions can provide
the majority of people with an acceptable alternative
support modality in a systematic and scalable way. Re-
search has found that telephone and internet-based sup-
port is particularly important for men with cancer,
predominately prostate cancer, living outside metropol-
itan regions in Australia [33]. Psycho-education and self-
directed therapeutic techniques can easily be transferred
to an online environment and may also break down the
barriers that many people face in terms of accessing sup-
port, including lack of available resources and perceived
and personal stigma, fear and uncertainty in accessing
mental health services [32,34]. Leykin et al. [25] criticised
current online resources for being predominately informa-
tion and support based, with a need for evidenced-based
treatment interventions.
The current study involves a randomised controlled
trial (RCT) assessing the effectiveness of three online in-
terventions: (i) access to an online intervention program
(My Road Ahead-only); (ii) access to the online interven-
tion plus to a moderated online forum (My Road Ahead-
plus-forum); and (iii) access to the online form only
(forum-only). This study design was chosen to evaluate
the online intervention in comparison to a more basic
level of care (some peer support) and to separate the effect
of the online intervention and the peer support forum on
treatment outcomes. Past RCTs have used a variety of
control conditions from wait-list control groups, care as
usual, or some basic information provision. Cuijpers et al.
[35] have criticised past internet-based RCTs for failing to
use control groups beyond a wait-list control, since there
may be an overestimation of intervention efficacy when
those in a wait-list control condition are unlikely to make
self-directed steps to improving their situation if they are
“waiting”. A web-based comparative condition has been
recommended to overcome these problems [36]. Basicmoderated forums have been used in previous studies
as a control group as a means to control for spontan-
eous improvement or to control for the general atten-
tion and the possible beneficial effects from sharing
one’s experience with others (e.g. [37,38]). In addition
online support groups may themselves have positive ef-
fects for people with cancer (e.g., [28,29]), and the use
of three groups would allow for exploration of the rela-
tive benefits of the online psychological intervention
and peer support (forum).
Method/design
Aims and hypotheses
The overall aim of the RCT is to examine the efficacy of
the online, self-directed, psychological intervention, My
Road Ahead alone versus My Road Ahead plus use of a
moderated online forum, versus the forum alone in im-
proving participants’ psychological distress as well as
sexual, relationship and psychosocial adjustment from
baseline to post-intervention, 3 months and 6 months
follow-up.
Primary outcome:
Psychological distress as measured by the combined
total score of the DASS-21 will be used as the primary
outcome measure.
It is hypothesised that:
1. Participants randomised to receive My Road Ahead,
with or without access to the forum, as compared to
those who receive access to the forum only
condition, will demonstrate significantly greater
reductions in psychological distress from pre- to
post-intervention and at 3 and 6 month follow-up.
2. Participants randomised to receive access to the
moderated forum in addition to My Road Ahead,
as compared to those who receive access only to
My Road Ahead, will demonstrate significantly
greater reduction in psychological distress from
pre- to post-intervention and at 3 and 6 month
follow-up.
Secondary outcomes:
It is hypothesised that:
1. Participants randomised to receive My Road Ahead,
with or without access to the forum, as compared to
those who receive access to the forum only
condition, will demonstrate significantly higher
quality of life as evidenced by measures of sexual
adjustment, sexual confidence and satisfaction,
masculine self-esteem, marital adjustment,
relationship conflict and relationship communication
style from pre- to post-intervention and at 3 and
6 month follow-up.
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It is hypothesised that:
1. Intervention driven reductions in psychological
distress will be mediated by masculine self-esteem
and moderated by sexual confidence and relationship
communication style.
Study design
This study is registered with the Australian New Zealand
Clinical Trials Registry; Identifier: ACTRN12611000278932.
Ethical approval to conduct the study has been obtained
from Melbourne Health, Swinburne University of Technol-
ogy, Deakin University and Peter MacCallum Cancer Centre
Human Research Ethics Committee’s. CONSORT [39] re-
quirements for RCTs will be adhered to throughout the
study.
Procedure
Participant consent will be obtained using an online
consent process. The consent form is provided to the
participant in PDF format. Participants are asked to con-
firm that they understand the study conditions, that they
have received a copy of the participant information and
that they consent to take part in the study by selecting
three check-boxes during the consent process. Partici-
pants will then move on to create a personal, password
protected account on the My Road Ahead website and
complete the baseline questionnaires. After completing
the baseline questionnaires participants will then be ran-
domly assigned using a computer generated sequential
1-to1- to 1 allocation across the three (3) groups. Partici-
pants and researchers involved in the management of
the project are not blinded to the randomisation out-
comes. Group 1 participants will receive access to My
Road Ahead, the 6 module online program. Group 2
participants will get access to My Road Ahead plus ac-
cess to the moderated forum. Group 3 participants will
receive access to the moderated forum only.
Participants in all groups will receive a weekly email re-
minder to return to the program and/or forum and to en-
courage them to continue to participate in the research
over the course of the 10 weeks of the intervention phase.
Participants will also receive three reminder emails to
complete the questionnaires at each time point.
Participants in all groups will undertake the online as-
sessment at five time points; baseline, week 5, post-
intervention (week 10 for group 3) and 12 weeks post
intervention (week 22 for group 3), and 6 months post-
intervention (see Figure 1).
Inclusion and exclusion
Eligibility criteria include participants having been diag-
nosed with localised prostate cancer and have receivedtreatment with curative intent (or currently receiving
treatment) within the last 5 years. They must not have a
diagnosis of advanced or metastatic disease. Participants
must be able to utilise a computer or mobile device and
have access to a connection to the internet at least once
per week for up to one hour. They must be able to read,
write and understand the English language without the
assistance of an interpreter.
Recruitment
Participants will be recruited across Australia with adver-
tisements published in various national and local newspa-
pers as well as on various health websites (including the
Prostate Cancer Foundation of Australia (www.prostate.
org.au), beyondblue (www.beyondblue.org.au), MensShed-
Online (www.theshedonline.org.au)). In addition partici-
pants will also be recruited via letters from urologists
and radiation oncologists practising at the collaborating
institutions including Royal Melbourne Hospital, Epworth
Healthcare and Peter MacCallum Cancer Centre. Partici-
pants will be recruited across a variety of locations so as
to maximise the recruitment of participants with a range
of demographic variables.
Randomisation
Participant consent and sign up to the study is conducted
entirely online and participants self-generate their user-
name and password so as to ensure privacy and confidenti-
ality. Randomisation is computer-generated on a sequential
basis once the participant has completed the baseline
questionnaire.
My road ahead: the online psychological intervention
My Road Ahead is a self-directed cognitive behavioural
therapy (CBT) based intervention that provides psycho-
education (through text, video, audio and graphics), a
series of interactive exercises and regular automated
feedback as participants progress through the program.
The program features videos of real case experiences
around coping with prostate cancer, as well as health
professionals providing expert commentary.
The intervention is a six (6) module online program
that offers a range of topics to work through at an indi-
vidual pace across a period of ten (10) weeks. All mod-
ules are available to participants from the beginning and
participants can use them in the order they chose, al-
though a recommended sequence from 1-6 is suggested
to participants.
Specific module themes are shown in Table 1.
The intervention also includes weekly offline exercises
that participants download and work through. Partici-
pants have the option to do these exercises alone or with
their partner; completion of exercises with the partner is
self-reported by participants at the post-intervention
Figure 1 Flow chart of participant movement through RCT.
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monitor that generates a graph of mood status over the
course of the intervention, a log book where men can
record their responses to the exercises, and a bookmark-
ing capability so men can return to pages of particular
interest.
Moderated forum:
The two moderated forum facilities are also hosted on
the website, however, participants who have access to
the forum in addition to the My Road Ahead program
will utilise a separate forum to those participants who
only have access to the forum alone, to avoid contamin-
ation across groups. Both forums are moderated by the
research team and offer a ‘virtual space’ for participants
to ask questions of each other. The forum content is
grouped by theme and participants are encouraged to
log in at least once per week and contribute to the
forum. The moderator posts a comment once per weekto generate conversation. Data is collected about the
number and frequency of forum posts for each user and
qualitative analysis of the forums will be conducted at
the conclusion of the study.
Primary outcome measure
Psychological distress
Distress will be measured using the Depression Anxiety
and Stress Scales (DASS-21) short version [40]. The
DASS-21 is a set of three self-report scales designed to
measure the negative emotional states of depression,
anxiety and stress as well as total distress [40]. Each of
the three DASS-21 scales contains 7 items. The depres-
sion scale measures dysphoria, hopelessness, devaluation
of life, self-deprecation, lack of interest/involvement, an-
hedonia and inertia. The anxiety scale measures auto-
nomic arousal, skeletal muscle effects, situational anxiety,
and subjective experience of anxious affect. The stress
Table 1 Themes of the modules within the My Road Ahead intervention
Module Themes
1. Prostate cancer and you • Psycho-education about common emotional responses to prostate cancer
• Normalisation through other men’s stories
• Interactive reflective exercises aimed at encouraging self-reflection and acknowledgement of emotional responses
2. Effective communication • Common communication challenges in context of prostate cancer
• Strategies to improve general and relationship communication
• Communication enhancement exercises to complete with partner or alone
3. Physical changes • Common physical changes following treatment for localised prostate cancer
• Exercises to overcome anxiety and avoidance in relation to incontinence
• Introduction to relaxation strategies
4. Sexuality and masculinity • Education and exercises targeting negative cognitions surrounding cancer and erectile dysfunction (ED)
• Skills training in general and sexual communication
• Education and exercises addressing masculinity and identity issues
5. Sexuality and intimacy • Sexual problems and cancer
• The impact of ED and cancer on the relationship
• Education and exercises designed to broaden definitions of sexuality and sexual behaviour to enhance sexual intimacy
• Education about the use of medical aids for ED
6. Planning for the future • Education and exercises related to fear and uncertainty about the future
• Planning for the future
• Encouragement of continued use of the skills developed from the intervention
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ritable and impatient. The total score is the sum of these
three subscale scores. Participants are asked to rate the ex-
tent to which they have experienced each state over the
past week, using a 4-point severity/frequency scale. The
DASS-21 scales have good concurrent validity with the
Beck measures of depression and anxiety (BDI & BAI)
and good internal consistency and reliability [40].
Secondary outcome measures
The prostate cancer-related quality of life scales (PCa-QoL)
The impact of erectile dysfunction on sexual and mascu-
line identity will be measured using the PCa-QoL [41],
which measures men’s perceptions of early prostate can-
cer treatment outcomes, focussing on behavioural, inter-
personal and emotional changes that patients attribute
to prostate cancer [41]. The scale contains 84 Likert type
items that fall into 11 scales including: 1. Urinary control
(behavioural and interpersonal implications of impaired
control of one’s bladder); 2. Sexual ability - sexual intimacy
(ability to perform sexually and feelings of frustration, em-
barrassment or failure); 3. Sexual confidence (confidence
and anxiety about intimate activity and sexual thoughts);
4. Spouse affection (misgivings about demonstrations of
affection with one’s spouse), 5. Masculine self-esteem;
6. Health worry (uncertainty about one’s health); 7. PSA
concern; 8. Cancer control; 9. Informed decision; 10. Regret;
and, 11. Positive outlook.International index of erectile function (IIEF)
The IIEF [42] is a 15-item self-report measure that was
developed to assess sexual function among men with
Erectile Dysfunction (ED) [42]. The IIEF instructs re-
spondents to answer items according to functioning
during the past 4 weeks. Responses to items are
summed to determine the total IIEF score (range 5–75).
Rosen et al. [42] reported high internal consistency, for
the total IIEF scale (α = 0.91), as well as high test-retest
reliability (r = 0.82).
Kansas marital satisfaction scale (KMS)
The KMS [43] is a common measure of relationship sat-
isfaction. It is a 3-item self-reported questionnaire meas-
uring general relationship satisfaction. Final scores on
the KMS range from 3 to 21 with higher scores indicat-
ing higher relationship satisfaction. A recent meta-
analysis of 398 articles evaluated the reliability of seven
different relationship satisfaction measures using Cron-
bach’s alpha estimates [44]. The authors found the KMS
to be the strongest overall measure based on reliability
alone with an average of r = .95 across studies.
Communication patterns questionnaire-short form (CPQ-SF)
The CPQ-SF [45,46] is an 11-item self-report question-
naire that measures communication within intimate re-
lationships. The CPQ-SF asks respondents to identify
typical communication styles when either issues or
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lems. Respondents are asked to rate the likelihood that
certain issues/problems occur on a 9-point scale from
very unlikely to very likely.
Dyadic sexual communication scale (DSC)
The DSC [47] was originally developed as a 13-item
scale to measure a respondent’s self-reported percep-
tion of their communication with their partner related
to sexual relationships. Subsequently, Choi, Catania,
and Dolcini [48] created a 4-item version of the DSC
scale. The short-form DSC has 4 items requesting rat-
ings on a 5-point scale: strongly disagree, disagree, neu-
tral, agree, and strongly agree. Reliability of the 4 item
version of the DSC was found to be acceptable taken
from a male sample as part of the larger study men-
tioned above (Cronbach’s alpha = .65) [48].
General confidence
Because of the strong link between sexual potency and
general confidence, a 1-item scale was created to assess
general confidence (I feel confident in most areas of my
life) which will be rated a 5-point scale: almost never/never
to almost always/always.
Healthcare service utilisation and demographics
Participants will also be asked to record the number of
contacts they have with additional support services in-
cluding psychiatrists, psychologists and social workers as
well as attending a support group or accessing support
from the cancer council or other online resources. De-
gree of engagement of the participant’s partner in the
program and completion of the exercises will also be
assessed post-intervention.
Demographic details include age, date of birth, marital
status, employment status, gross annual income, ethni-
city, languages spoken. Other participant details includ-
ing postcode, prostate cancer date of diagnosis, date of
treatment, type of treatment, use of oral erectile function
medications (e.g. use of Viagra or cialis), use of injection
therapies for erectile function (e.g. Caverject injections),
and use of other mechanical aids for erectile function
will also be collected.
Program and forum satisfaction questionnaires
Program completion will be tracked and recorded
through the online system which will allow reporting of
the proportion of the program completed by each user
as well as details about which modules are most
accessed. A questionnaire has been developed for this
study for the purpose of measuring the level of program
satisfaction and level of inclusion of partners. Respon-
dents will be presented with open-ended questions relat-
ing to the “best” and “worst” parts of the program andhow the program could be improved, including any add-
itional features they might find useful. If men do not
work through all the modules they will be asked for rea-
sons. An equivalent questionnaire has been developed to
measure satisfaction with the moderated forum.
Participants
A medium effect size is estimated for the primary out-
come measure, total distress, as measured by the DASS-
21 total score between groups across the five assessment
points. To power the study at the 80% level, based on an
alpha level of .05 with an estimated medium effect size
(f = .25) and with three groups completing five assess-
ment points, 125 complete responses will be required.
To account for an estimated 20% drop-out rate a total of
150 participants will be required; 50 per group.
Statistical analyses
Data will be analysed using repeated measures Multivari-
ate Analysis of Variance (MANOVA) with between and
within subjects factors examined while controlling for
age. To examine any bias that may arise as a conse-
quence of attrition, baseline data will be examined to ex-
plore if there are any statistically significant factors
associated with participants who drop out compared to
those who do not. This will allow an analysis for attrition
bias in the final results based on the predicted probability
of attrition as recommended by Rubin [49] and Heckman
[50]. An intention to treat analysis and then longitudinal
hierarchical linear model analyses will be performed
[51,52], avoiding the need for the imputation of missing
data.
Discussion
To our knowledge, My Road Ahead is the first self-
directed online psychological intervention developed for
localised prostate cancer. The RCT will assess the effi-
cacy of this intervention in improving psychological
well-being, sexual satisfaction, relationship satisfaction
and overall quality of life. If successful this intervention
could provide much needed support to men receiving
treatment for localised prostate cancer in an accessible,
appealing and accessible manner.
This study aims to evaluate the effectiveness of the de-
veloped intervention by comparing the outcomes of par-
ticipants who receive access to My Road Ahead, with or
without access to a forum, to the outcomes of partici-
pants who receive access to a forum only. This design
enables evaluation of the benefits of the peer discussion
forum in addition to the developed intervention. This
novel approach to evaluation of the contribution of the
peer discussion forum will provide much needed data
about the role of psychological strategies and peer
discussion.
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men treated for prostate cancer is a significant problem
worldwide. Integration of psychosocial services within
the treatment team is very rare and patient reported un-
met needs in this domain are very high. If My Road
Ahead is successful we hope to be able to provide access
to the program to all men treated for localised prostate
cancer in Australia thereby increasing access by reducing
barriers to access as well as reducing stigma associated
with accessing psychosocial services.Competing interests
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